Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
Story summaryThe market share of India's most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies.
Read at CNBCOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.